Clinical trialPhase 3
BROADWAY (obicetrapib)
NCT05142722
Obicetrapib на фоне lipid-lowering therapy; LDL-C effect, не доказательство регрессии бляшки.
No news refers to this card yet.
Also in the catalogue
- CORALreef OutcomesClinical trial
- OCEAN(a)-OutcomesClinical trial
- REMBRANDTClinical trial
- ACCLAIM-CTAClinical trial
- VICTORION-PLAQUE (inclisiran)Clinical trial
- ACCLAIM-Lp(a)Clinical trial
Scales
Identifiers
- NCT
- NCT05142722
Original sources
Details
- Phase
- Phase 3
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.